Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors.
Bioorg Med Chem
; 28(23): 115815, 2020 12 01.
Article
in En
| MEDLINE
| ID: mdl-33091850
Full text:
1
Database:
MEDLINE
Main subject:
Quinazolines
/
Protein Kinase Inhibitors
/
Interleukin-1 Receptor-Associated Kinases
Limits:
Animals
/
Humans
Language:
En
Year:
2020
Type:
Article